Nelson Hardiman managing partner Harry Nelson presented at the 13th Annual Family Office Investment Symposium where he discussed the four main buckets of potential life sciences investing, including 1) pharma/biotech, 2) medical devices, 3) neutraceuticals, supplements, and cosmeceuticals, and 4) clinical research and technology transfer.
Posted on February 27, 2018
Recent Posts
Harry Nelson Interviewed on BBC News: US to require negative Covid tests for travelers from ChinaHarry Nelson Interviewed on NewsNation Banfield: Fears over old sports medical forms and girls menstrual informationA View from Legal Street, Help Us Help You Get Paid, Episode 14: The Revenue Solution – TJ FerrisHarry Nelson Interviewed on KTLA 5 regarding the rise in fentanyl deaths amid $650M pharmacy judgmentHarry Nelson on NewsNation Rush Hour Discussing the Monkeypox Outbreak